SlideShare a Scribd company logo
MAST/MISS TLIF
effect of Age, BMI & Comorbidity in 200 patients




     Petrus Stone, Neurosurgeon, Private Practice
             Bloemfontein, South Africa
                     2013-04-06
Disclosures

 MAST/MISS
  Teaching on behalf
  of Medtronic
 Sponsored
  attendance/travel
 Study at my own
  expense
 No animals were
  harmed
Literature

 OPEN surgery
   Age – more
    complicated
   BMI – more
    complicated
   Comorbidity - more
    complicated
 MI/MAST
   Age – some studies
   BMI – some studies
   Co-morbidity – no
    comparisons
Family debate– MISS Pros & Cons

 Advantages (theoretical)
    Cosmesis,
    Pain,
    Hospital Stay,
    Blood Loss,
    Infection
 Disadvantages (theoretical)
    Fusion Rate,
    Steep Learning Curve,
    Irradiation exposure
Objective


 To what degree does
  co-morbidity affect
  (short term) outcome
 Use of Information
    Patient/procedure
     selection
    Resource allocation
     (length of stay, High
     Care nights,
     transfusion,
     Physicians)
Patients / Materials And
Methods

 200 consecutive degenerative TLIF
  cases since 2009-08-31
 Review case notes, hospital notes
  (myself; senior nurse)
 Excluded 6 cases
    1x conversion to open
    1x aborted procedure (revision of
     open TLIF; screw holes too big)
    1x cancellation on table (medical
     aid interference)
    3 trauma thoraco-lumbar cases
 Stat analysis by UFS statistician
Descriptive Stats – The Procedures
 Surgical Time
     Median 3 hours (1h25-9h30) (case
      no 9; 3 levels)
 Levels operated / Orange River TLIF
   Class
     1: 56.5%
            A: 39%
            B-F: 15%
     2: 40%
            A: 24.5%
                                         TLIF sub-classes to accommodate for extra
            B-F: 15.5%
                                         work
     3: 3.5%                            •   a – no extra work
            A: 2.5%                     •   b – 30 minutes
                                         •   c – 60 minutes
            B-F: 1.0%                   •   Etc
 Medtronic : n = 181 (90.5%)            Examples
                                         •   Vertebroplasty;
 Navigation: n = 8 (4%)                 •   adjacent level discectomy;
 Radiation exposure: median 3.1         •   Same level wide decompression/lami;
  minutes                                •   Remove instrumentation
Descriptive Stats – Short term Outcome
Major                              Duration follow up: 30-880
• threatening to life or limb       days
  function
• Early revision surgery           Length of ICU/High Care
Moderate                            stay
• prolonged hospital stay or          0 nights: 14,5%
  outpatient treatment required
Minor                                 1 night: 75.5%
• inconvenient                        2 nights: 9.5%
                                   Length of postoperative
                                    hospital stay
                                      Median 3.9 days (0.9 to
                                       17.9)
                                   Need for transfusion
                                      3.5%
Significant Complications

Moderate local complications                     %
                                                          Moderate systemic complications                   %
durotomies                                      7.5%

superficial sepsis                              1.0%      respiratory (chest infection, atelectasis,
                                                          sleep apnoea)                                  4.5%
iatrogenic end plate damage --> extra screws    0.5%

partial L5 weakness 1 (0.5%)                    0.5%
                                                          arrhythmia                                     0.5%
persisting dysesthetic leg pain                 0.5%

plunge with PAK needle (uncomplicated)          0.5%      quadriceps hematoma                            0.5%
screw too deep, Hb drop                         0.5%

                                                11.0%                                                    5.5%




Major local complications                 %             Major systemic complications                    %
decompression same stay                  1.0%           Pulmonary embolism                             1.5%
fusion extension same stay               0.5%           Unexpected epileptic fit                       0.5%
severe L4 nerve root damage              0.5%           tachy-arythmia -> cardioversion                0.5%
                                         2.0%                                                          2.5%
Age effect
Group name                     Age Group 2
Subgroup names                        <65               >65
Fisher’s Exact Test                    %                 %         p-value Sig?      Worse
Transfusion required                          2.41             8.82 0.0969 -         • Transfusion if >70:
Durotomy/CSF leak
Local (major)
                                              6.63
                                              1.81
                                                              11.76 0.2918 -
                                                               2.94 0.5284 -
                                                                                       15.8%
Local (moderate)                              9.64            17.65 0.2241 -         • LOS if >70: 3.8 vs
Local (minor)                                 0.60             0.00 1.0000 -           3.9 vs 5.7 days
                                                                                     • ICU stay (hours not
Local (All: M, M, M)                         12.05            20.59 0.4077 -
Systemic (major)                              2.41             2.94 1.0000 -
Systemic (moderate)                           4.82             8.82 0.4028 -           nights) if >65
Systemic (minor)                             18.07            29.41 0.1577 -
Systemic (all)                               25.30            41.17    0.1415 -
Local or Systemic (major)                     4.22             5.88    0.6515 -      Similar
Local or Systemic (moderate)                 14.46            26.47    0.1914 -      • Complications
Local or Systemic (minor)                    18.67            29.41    0.1577 -
                                                                                     • Theater, Cutting,
Significant blood loss
                               1 night: 75.9%; 2
                                                 1 night: 75.76%; 2
                                                                                       Radiation time
                               nights: 6.63%
ICU nights                                       nights 24.24%         0.0005 Yes
Kruskal-Wallis Test                 Median            Median          p-value Sig?
LOS postop (days)                             3.80             4.90    0.0451 Yes
Theater Time (hours)                          4.10             4.30    0.4115 -
Cutting Time (hours)                          3.00             3.10    0.5770 -
ICU stay (hours)                             20.50            21.70    0.0020 Yes
Radiation Exposure (mins)                     3.10             3.10    0.6888 -
BMI effect
Group name                  BMI                          BMI Group 3
Subgroup names              <35        >35               <35     35-40 >40
Fisher’s Exact Test         %          %          p-value %      %     %     p-value
Transfusion required            3.45       3.64    1.0000 3.45   0.00 7.69    0.2114
Durotomy/CSF leak               8.28       5.45    0.7642 8.28   6.90 3.85    0.9088
Local (major)                   1.38       3.64    0.3038 1.38   6.90 0.00    0.1821   Worse
                                                                                       • ICU nights
Local (moderate)             12.41         7.27    0.4478 12.41 10.34 3.85    0.5757
Local (minor)                   0.00       1.82    0.2750 0.00   0.00 3.85    0.1300

                                                                                       • Theater, Cutting, RE
Local (All: M, M, M)         13.79      12.73      0.1729 13.79 17.24 7.70    0.1149
Systemic (major)                2.76       1.82    1.0000 2.76   0.00 3.85    0.6015
Systemic (moderate)
Systemic (minor)
                                4.83
                             18.62
                                           7.27
                                        23.64
                                                   0.4985 4.83   6.90 7.69    0.6770
                                                   0.4338 18.62 24.14 23.08 0.6583
                                                                                         time
Systemic (all)               26.21      32.73      0.8746 26.21 31.04 34.62 0.9190
Local or Systemic (major)       4.14       5.46    0.7084 4.14   6.90 3.85    0.8519
Local or Systemic
(moderate)                   17.24      14.54      0.6623 17.24 17.24 11.54 0.9036
                                                                                       Similar
Local or Systemic (minor)
ICU - zero nights
                             18.62
                             17.36
                                        25.46
                                           7.27
                                                   0.4338 18.62 24.14 26.93 0.6583
                                                          17.36 13.79 0.00
                                                                                       • Complications
ICU - one night              75.69      76.36 0.0381 75.69 68.97 84.62 0.0312
                                                     6.94 17.24 15.38
                                                                                       • Hospital LOS
ICU - two night                 6.94    16.36
ICU nights
Kruskal-Wallis Test         median median p-value                            p-value
LOS postop (days)               3.90       4.00    0.1588 3.90   3.90 4.40    0.3392
Theater Time (hours)            4.00       4.70    0.0209 4.00   4.60 5.20    0.0245
Cutting Time (hours)            2.80       3.50    0.0163 2.80   3.20 3.80    0.0216
ICU stay (hours)             21.00      22.00      0.1765 21.00 20.40 23.00 0.1687
Radiation Exposure (mins)       3.00       3.70    0.0153 3.00   3.00 5.30    0.0012
Comorbidity (ASA) effect
Group name                     ASA score                                 ASA_Ex_BMI
Subgroup names                 ASA 1       ASA 2    ASA 3                ASA 1    ASA 2 ASA 3
Fisher’s Exact Test                %          %        %     p-value        %       %      %      p-value
Transfusion required              1.89      4.55     3.39       0.8867     1.59    4.69   0.00       0.5883
Durotomy/CSF leak                 9.43      7.95     5.08       0.6999     7.94    7.81   0.00       1.0000
Local (major)                     0.00      2.27     3.39       0.5810     0.00    3.13   0.00       0.4221   Summary
Local (moderate)                 15.09      11.36    6.78       0.3714 14.29      10.16   0.00       0.5071
Local (minor)                     0.00      0.00     1.69       0.5600     0.00    0.78   0.00       1.0000
                                                                                                              More likely
Local (All: M, M, M)             15.09      13.63    11.86      0.4548 14.29      14.07   0.00       0.6124
Systemic (major)                  3.77      2.27     1.69       0.7278     3.17    2.34   0.00       0.7349   • Minor & Moderate
Systemic (moderate)               1.89      6.82     6.78       0.4513     1.59    6.25   22.22      0.0491     systemic Cx
Systemic (minor)                 13.21      21.59    23.73      0.3462 11.11      22.66   44.44      0.0255   • Theater & Cutting
Systemic (all)                   18.87      30.68    32.20      0.6372 15.87      31.25   66.66      0.0358
                                                                                                                time
Local or Systemic (major)         3.77      4.54     5.08       1.0000     3.17    5.47   0.00       0.8168
Local or Systemic (moderate)     16.98      18.18    13.56      0.6589 15.88      16.41   22.22      0.7344
                                                                                                              • ICU stay? (integar
Local or Systemic (minor)        13.21      21.59    25.42      0.3462 11.11      23.44   44.44      0.0255     nights; not hours)
ICU - zero nights                26.42      12.64    6.78                 26.98    9.45   0.00
ICU - one night                  66.04      81.61    76.27    0.0115      66.67   81.10   66.67    0.0034
                                                                                                              Similar occurrence
                                                                                                              • Local Cx
ICU - two night                   7.55      5.75     16.95                 6.35    9.45   33.33
Kruskal-Wallis Test            median      median median p-value                                  p-value
LOS postop (days)                 3.80      3.90     4.00       0.2550     3.60    4.00   4.00       0.0857   • Major Systemic Cx
Theater Time (hours)              3.60      4.20     4.70       0.0063     3.50    4.50   4.10       0.0008   • Transfusion
Cutting Time (hours)              2.60      2.90     3.50       0.0153     2.40    3.30   2.90       0.0045   • ICU nights (hours
                                                                                                                not nights)
ICU stay (hours)                 20.20      21.10    22.00      0.1933 20.20      21.10   25.20      0.0362
Radiation Exposure (mins)         2.90      3.00     3.70       0.0509     2.90    3.30   2.90       0.1182
                                                                                                              • LOS
Summary
 Age
   >70: longer LOS (4 vs 6 days)
   >70: transfusion more likely
    (15 vs 2%)
   >65: ICU stay (hours not
    nights)
   ISQ complications
 BMI
   Longer procedure, theater
    time, irradiation time
   More ICU nights
   ISQ complications & LOS
 Comorbidity (ASA score)
   Longer procedure
   ISQ complications & LOS

More Related Content

Viewers also liked

Lumbar interbody fusion indications techniques and complications
Lumbar interbody fusion indications techniques and complicationsLumbar interbody fusion indications techniques and complications
Lumbar interbody fusion indications techniques and complications
Dr Praveen kumar tripathi
 
Religion diet
Religion dietReligion diet
Religion diet
17WeidingerN
 
Kenapa Mainan Edukatif
Kenapa Mainan EdukatifKenapa Mainan Edukatif
Kenapa Mainan Edukatifhanomanise
 
Presentation practice slides
Presentation practice slidesPresentation practice slides
Presentation practice slides
17WeidingerN
 
Síntesis de evaluación
Síntesis de evaluaciónSíntesis de evaluación
Síntesis de evaluación
Óscar Fernando Zúñiga Peña
 
Jelly bean
Jelly beanJelly bean
Jelly bean
mobiplaybook
 
Presentation2 why and how bears began
Presentation2  why and how bears beganPresentation2  why and how bears began
Presentation2 why and how bears began
Claire Goldstein
 
Kyle Roberts Visual Resume
Kyle Roberts Visual ResumeKyle Roberts Visual Resume
Kyle Roberts Visual Resume
KyleKar
 
South africa
South africaSouth africa
South africa
ingles102012
 
VIDBOX_-Overview-june-15-2015
VIDBOX_-Overview-june-15-2015VIDBOX_-Overview-june-15-2015
VIDBOX_-Overview-june-15-2015
Jorge Olson
 
Oriflame opportunity in Viet Nam
Oriflame opportunity in Viet NamOriflame opportunity in Viet Nam
Oriflame opportunity in Viet NamHương Nguyễn
 
Festa dell'Adesione di AC Crocetta
Festa dell'Adesione di AC CrocettaFesta dell'Adesione di AC Crocetta
Festa dell'Adesione di AC Crocetta
Marco Mazzaglia
 
Evaluation for preliminary task
Evaluation for preliminary taskEvaluation for preliminary task
Evaluation for preliminary task
sammarlow
 
Konsument ok
Konsument okKonsument ok
Konsument okankowy
 
5º tic en zootopia
5º tic en zootopia5º tic en zootopia
5º tic en zootopia
Camilo Rodriguez MAcias
 
Green demo 2
Green demo 2 Green demo 2
Green demo 2 namie0422
 
Crown capital management
Crown capital managementCrown capital management
Crown capital management
Freddie Cotter
 
Changing Context
Changing ContextChanging Context
Changing Context
ajevans55
 
La inteligencia
La inteligenciaLa inteligencia
La inteligencia
Juan1413
 

Viewers also liked (20)

Lumbar interbody fusion indications techniques and complications
Lumbar interbody fusion indications techniques and complicationsLumbar interbody fusion indications techniques and complications
Lumbar interbody fusion indications techniques and complications
 
Religion diet
Religion dietReligion diet
Religion diet
 
Kenapa Mainan Edukatif
Kenapa Mainan EdukatifKenapa Mainan Edukatif
Kenapa Mainan Edukatif
 
Presentation practice slides
Presentation practice slidesPresentation practice slides
Presentation practice slides
 
Síntesis de evaluación
Síntesis de evaluaciónSíntesis de evaluación
Síntesis de evaluación
 
Jelly bean
Jelly beanJelly bean
Jelly bean
 
Presentation2 why and how bears began
Presentation2  why and how bears beganPresentation2  why and how bears began
Presentation2 why and how bears began
 
Kyle Roberts Visual Resume
Kyle Roberts Visual ResumeKyle Roberts Visual Resume
Kyle Roberts Visual Resume
 
South africa
South africaSouth africa
South africa
 
VIDBOX_-Overview-june-15-2015
VIDBOX_-Overview-june-15-2015VIDBOX_-Overview-june-15-2015
VIDBOX_-Overview-june-15-2015
 
Oriflame opportunity in Viet Nam
Oriflame opportunity in Viet NamOriflame opportunity in Viet Nam
Oriflame opportunity in Viet Nam
 
Festa dell'Adesione di AC Crocetta
Festa dell'Adesione di AC CrocettaFesta dell'Adesione di AC Crocetta
Festa dell'Adesione di AC Crocetta
 
Evaluation for preliminary task
Evaluation for preliminary taskEvaluation for preliminary task
Evaluation for preliminary task
 
Konsument ok
Konsument okKonsument ok
Konsument ok
 
5º tic en zootopia
5º tic en zootopia5º tic en zootopia
5º tic en zootopia
 
Green demo 2
Green demo 2 Green demo 2
Green demo 2
 
Crown capital management
Crown capital managementCrown capital management
Crown capital management
 
Changing Context
Changing ContextChanging Context
Changing Context
 
La inteligencia
La inteligenciaLa inteligencia
La inteligencia
 
Foods
FoodsFoods
Foods
 

Similar to MI-TLIF - effect of age, BMI& comorbidity - 2013-04-06 - global spine congress, hong kong

Economic evaluation. Methods for adjusting survival estimates in the presence...
Economic evaluation. Methods for adjusting survival estimates in the presence...Economic evaluation. Methods for adjusting survival estimates in the presence...
Economic evaluation. Methods for adjusting survival estimates in the presence...
HTAi Bilbao 2012
 
Tavi
TaviTavi
Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)
escts2012
 
Using NSQIP to calculate mortality risk from NSTIs
Using NSQIP to calculate mortality risk from NSTIsUsing NSQIP to calculate mortality risk from NSTIs
Using NSQIP to calculate mortality risk from NSTIs
Amalia Cochran
 
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Sociedad Latinoamericana de Cardiología Intervencionista
 
Hamon M 201111
Hamon M 201111Hamon M 201111
Vte予防 講義
Vte予防 講義Vte予防 講義
Vte予防 講義
Katsushige Takagishi
 
Medical Sample 23
Medical  Sample 23Medical  Sample 23
Medical Sample 23
SkyeCreativeMedia
 
ACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic ReviewsACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic Reviews
bnolke
 
Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)
fondas vakalis
 
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Cristiano Amarelli
 
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Health Informatics New Zealand
 
Schuez
SchuezSchuez
Aha lbct
Aha lbctAha lbct
AHA: LBCT
AHA: LBCTAHA: LBCT
Robotic-Assisted Pyeloplasty
Robotic-Assisted PyeloplastyRobotic-Assisted Pyeloplasty
Robotic-Assisted Pyeloplasty
Urovideo.org
 
Aha2009 1055
Aha2009 1055Aha2009 1055
Aha2009 1055
hospital
 
Radiosurgery in brain tumours
Radiosurgery in brain tumoursRadiosurgery in brain tumours
Radiosurgery in brain tumours
elango mk
 
Accidents In Radiation Therapy
Accidents In Radiation TherapyAccidents In Radiation Therapy
Accidents In Radiation Therapy
fondas vakalis
 
Bone sarcoma
Bone sarcomaBone sarcoma

Similar to MI-TLIF - effect of age, BMI& comorbidity - 2013-04-06 - global spine congress, hong kong (20)

Economic evaluation. Methods for adjusting survival estimates in the presence...
Economic evaluation. Methods for adjusting survival estimates in the presence...Economic evaluation. Methods for adjusting survival estimates in the presence...
Economic evaluation. Methods for adjusting survival estimates in the presence...
 
Tavi
TaviTavi
Tavi
 
Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)Impact of previous stenting on the outcome of (2)
Impact of previous stenting on the outcome of (2)
 
Using NSQIP to calculate mortality risk from NSTIs
Using NSQIP to calculate mortality risk from NSTIsUsing NSQIP to calculate mortality risk from NSTIs
Using NSQIP to calculate mortality risk from NSTIs
 
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
Revascularización miocárdica sin bomba; iguales resultados al año que la ciru...
 
Hamon M 201111
Hamon M 201111Hamon M 201111
Hamon M 201111
 
Vte予防 講義
Vte予防 講義Vte予防 講義
Vte予防 講義
 
Medical Sample 23
Medical  Sample 23Medical  Sample 23
Medical Sample 23
 
ACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic ReviewsACE: The First Experience with Angiographic Reviews
ACE: The First Experience with Angiographic Reviews
 
Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)Future Rt Cco (0sullivan)
Future Rt Cco (0sullivan)
 
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
Amarelli 313 Transplantation Ii Early Graft Failure After Heart Transplant Le...
 
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...Now you see them, now you don't: the usefulness of data auditing in EHR devel...
Now you see them, now you don't: the usefulness of data auditing in EHR devel...
 
Schuez
SchuezSchuez
Schuez
 
Aha lbct
Aha lbctAha lbct
Aha lbct
 
AHA: LBCT
AHA: LBCTAHA: LBCT
AHA: LBCT
 
Robotic-Assisted Pyeloplasty
Robotic-Assisted PyeloplastyRobotic-Assisted Pyeloplasty
Robotic-Assisted Pyeloplasty
 
Aha2009 1055
Aha2009 1055Aha2009 1055
Aha2009 1055
 
Radiosurgery in brain tumours
Radiosurgery in brain tumoursRadiosurgery in brain tumours
Radiosurgery in brain tumours
 
Accidents In Radiation Therapy
Accidents In Radiation TherapyAccidents In Radiation Therapy
Accidents In Radiation Therapy
 
Bone sarcoma
Bone sarcomaBone sarcoma
Bone sarcoma
 

Recently uploaded

Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 

Recently uploaded (20)

Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 

MI-TLIF - effect of age, BMI& comorbidity - 2013-04-06 - global spine congress, hong kong

  • 1. MAST/MISS TLIF effect of Age, BMI & Comorbidity in 200 patients Petrus Stone, Neurosurgeon, Private Practice Bloemfontein, South Africa 2013-04-06
  • 2. Disclosures  MAST/MISS Teaching on behalf of Medtronic  Sponsored attendance/travel  Study at my own expense  No animals were harmed
  • 3. Literature  OPEN surgery  Age – more complicated  BMI – more complicated  Comorbidity - more complicated  MI/MAST  Age – some studies  BMI – some studies  Co-morbidity – no comparisons
  • 4. Family debate– MISS Pros & Cons  Advantages (theoretical)  Cosmesis,  Pain,  Hospital Stay,  Blood Loss,  Infection  Disadvantages (theoretical)  Fusion Rate,  Steep Learning Curve,  Irradiation exposure
  • 5. Objective  To what degree does co-morbidity affect (short term) outcome  Use of Information  Patient/procedure selection  Resource allocation (length of stay, High Care nights, transfusion, Physicians)
  • 6. Patients / Materials And Methods  200 consecutive degenerative TLIF cases since 2009-08-31  Review case notes, hospital notes (myself; senior nurse)  Excluded 6 cases  1x conversion to open  1x aborted procedure (revision of open TLIF; screw holes too big)  1x cancellation on table (medical aid interference)  3 trauma thoraco-lumbar cases  Stat analysis by UFS statistician
  • 7.
  • 8. Descriptive Stats – The Procedures  Surgical Time  Median 3 hours (1h25-9h30) (case no 9; 3 levels)  Levels operated / Orange River TLIF Class  1: 56.5%  A: 39%  B-F: 15%  2: 40%  A: 24.5% TLIF sub-classes to accommodate for extra  B-F: 15.5% work  3: 3.5% • a – no extra work  A: 2.5% • b – 30 minutes • c – 60 minutes  B-F: 1.0% • Etc  Medtronic : n = 181 (90.5%) Examples • Vertebroplasty;  Navigation: n = 8 (4%) • adjacent level discectomy;  Radiation exposure: median 3.1 • Same level wide decompression/lami; minutes • Remove instrumentation
  • 9. Descriptive Stats – Short term Outcome Major  Duration follow up: 30-880 • threatening to life or limb days function • Early revision surgery  Length of ICU/High Care Moderate stay • prolonged hospital stay or  0 nights: 14,5% outpatient treatment required Minor  1 night: 75.5% • inconvenient  2 nights: 9.5%  Length of postoperative hospital stay  Median 3.9 days (0.9 to 17.9)  Need for transfusion  3.5%
  • 10. Significant Complications Moderate local complications % Moderate systemic complications % durotomies 7.5% superficial sepsis 1.0% respiratory (chest infection, atelectasis, sleep apnoea) 4.5% iatrogenic end plate damage --> extra screws 0.5% partial L5 weakness 1 (0.5%) 0.5% arrhythmia 0.5% persisting dysesthetic leg pain 0.5% plunge with PAK needle (uncomplicated) 0.5% quadriceps hematoma 0.5% screw too deep, Hb drop 0.5% 11.0% 5.5% Major local complications % Major systemic complications % decompression same stay 1.0% Pulmonary embolism 1.5% fusion extension same stay 0.5% Unexpected epileptic fit 0.5% severe L4 nerve root damage 0.5% tachy-arythmia -> cardioversion 0.5% 2.0% 2.5%
  • 11. Age effect Group name Age Group 2 Subgroup names <65 >65 Fisher’s Exact Test % % p-value Sig? Worse Transfusion required 2.41 8.82 0.0969 - • Transfusion if >70: Durotomy/CSF leak Local (major) 6.63 1.81 11.76 0.2918 - 2.94 0.5284 - 15.8% Local (moderate) 9.64 17.65 0.2241 - • LOS if >70: 3.8 vs Local (minor) 0.60 0.00 1.0000 - 3.9 vs 5.7 days • ICU stay (hours not Local (All: M, M, M) 12.05 20.59 0.4077 - Systemic (major) 2.41 2.94 1.0000 - Systemic (moderate) 4.82 8.82 0.4028 - nights) if >65 Systemic (minor) 18.07 29.41 0.1577 - Systemic (all) 25.30 41.17 0.1415 - Local or Systemic (major) 4.22 5.88 0.6515 - Similar Local or Systemic (moderate) 14.46 26.47 0.1914 - • Complications Local or Systemic (minor) 18.67 29.41 0.1577 - • Theater, Cutting, Significant blood loss 1 night: 75.9%; 2 1 night: 75.76%; 2 Radiation time nights: 6.63% ICU nights nights 24.24% 0.0005 Yes Kruskal-Wallis Test Median Median p-value Sig? LOS postop (days) 3.80 4.90 0.0451 Yes Theater Time (hours) 4.10 4.30 0.4115 - Cutting Time (hours) 3.00 3.10 0.5770 - ICU stay (hours) 20.50 21.70 0.0020 Yes Radiation Exposure (mins) 3.10 3.10 0.6888 -
  • 12. BMI effect Group name BMI BMI Group 3 Subgroup names <35 >35 <35 35-40 >40 Fisher’s Exact Test % % p-value % % % p-value Transfusion required 3.45 3.64 1.0000 3.45 0.00 7.69 0.2114 Durotomy/CSF leak 8.28 5.45 0.7642 8.28 6.90 3.85 0.9088 Local (major) 1.38 3.64 0.3038 1.38 6.90 0.00 0.1821 Worse • ICU nights Local (moderate) 12.41 7.27 0.4478 12.41 10.34 3.85 0.5757 Local (minor) 0.00 1.82 0.2750 0.00 0.00 3.85 0.1300 • Theater, Cutting, RE Local (All: M, M, M) 13.79 12.73 0.1729 13.79 17.24 7.70 0.1149 Systemic (major) 2.76 1.82 1.0000 2.76 0.00 3.85 0.6015 Systemic (moderate) Systemic (minor) 4.83 18.62 7.27 23.64 0.4985 4.83 6.90 7.69 0.6770 0.4338 18.62 24.14 23.08 0.6583 time Systemic (all) 26.21 32.73 0.8746 26.21 31.04 34.62 0.9190 Local or Systemic (major) 4.14 5.46 0.7084 4.14 6.90 3.85 0.8519 Local or Systemic (moderate) 17.24 14.54 0.6623 17.24 17.24 11.54 0.9036 Similar Local or Systemic (minor) ICU - zero nights 18.62 17.36 25.46 7.27 0.4338 18.62 24.14 26.93 0.6583 17.36 13.79 0.00 • Complications ICU - one night 75.69 76.36 0.0381 75.69 68.97 84.62 0.0312 6.94 17.24 15.38 • Hospital LOS ICU - two night 6.94 16.36 ICU nights Kruskal-Wallis Test median median p-value p-value LOS postop (days) 3.90 4.00 0.1588 3.90 3.90 4.40 0.3392 Theater Time (hours) 4.00 4.70 0.0209 4.00 4.60 5.20 0.0245 Cutting Time (hours) 2.80 3.50 0.0163 2.80 3.20 3.80 0.0216 ICU stay (hours) 21.00 22.00 0.1765 21.00 20.40 23.00 0.1687 Radiation Exposure (mins) 3.00 3.70 0.0153 3.00 3.00 5.30 0.0012
  • 13. Comorbidity (ASA) effect Group name ASA score ASA_Ex_BMI Subgroup names ASA 1 ASA 2 ASA 3 ASA 1 ASA 2 ASA 3 Fisher’s Exact Test % % % p-value % % % p-value Transfusion required 1.89 4.55 3.39 0.8867 1.59 4.69 0.00 0.5883 Durotomy/CSF leak 9.43 7.95 5.08 0.6999 7.94 7.81 0.00 1.0000 Local (major) 0.00 2.27 3.39 0.5810 0.00 3.13 0.00 0.4221 Summary Local (moderate) 15.09 11.36 6.78 0.3714 14.29 10.16 0.00 0.5071 Local (minor) 0.00 0.00 1.69 0.5600 0.00 0.78 0.00 1.0000 More likely Local (All: M, M, M) 15.09 13.63 11.86 0.4548 14.29 14.07 0.00 0.6124 Systemic (major) 3.77 2.27 1.69 0.7278 3.17 2.34 0.00 0.7349 • Minor & Moderate Systemic (moderate) 1.89 6.82 6.78 0.4513 1.59 6.25 22.22 0.0491 systemic Cx Systemic (minor) 13.21 21.59 23.73 0.3462 11.11 22.66 44.44 0.0255 • Theater & Cutting Systemic (all) 18.87 30.68 32.20 0.6372 15.87 31.25 66.66 0.0358 time Local or Systemic (major) 3.77 4.54 5.08 1.0000 3.17 5.47 0.00 0.8168 Local or Systemic (moderate) 16.98 18.18 13.56 0.6589 15.88 16.41 22.22 0.7344 • ICU stay? (integar Local or Systemic (minor) 13.21 21.59 25.42 0.3462 11.11 23.44 44.44 0.0255 nights; not hours) ICU - zero nights 26.42 12.64 6.78 26.98 9.45 0.00 ICU - one night 66.04 81.61 76.27 0.0115 66.67 81.10 66.67 0.0034 Similar occurrence • Local Cx ICU - two night 7.55 5.75 16.95 6.35 9.45 33.33 Kruskal-Wallis Test median median median p-value p-value LOS postop (days) 3.80 3.90 4.00 0.2550 3.60 4.00 4.00 0.0857 • Major Systemic Cx Theater Time (hours) 3.60 4.20 4.70 0.0063 3.50 4.50 4.10 0.0008 • Transfusion Cutting Time (hours) 2.60 2.90 3.50 0.0153 2.40 3.30 2.90 0.0045 • ICU nights (hours not nights) ICU stay (hours) 20.20 21.10 22.00 0.1933 20.20 21.10 25.20 0.0362 Radiation Exposure (mins) 2.90 3.00 3.70 0.0509 2.90 3.30 2.90 0.1182 • LOS
  • 14. Summary  Age  >70: longer LOS (4 vs 6 days)  >70: transfusion more likely (15 vs 2%)  >65: ICU stay (hours not nights)  ISQ complications  BMI  Longer procedure, theater time, irradiation time  More ICU nights  ISQ complications & LOS  Comorbidity (ASA score)  Longer procedure  ISQ complications & LOS